The search for the CD8+ cell anti-HIV factor (CAF)

被引:106
作者
Levy, JA [1 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
关键词
D O I
10.1016/j.it.2003.10.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Efforts to control HIV infection have led to the development of several antiretroviral drugs that can limit virus replication, however, these therapies do not offer a long-term solution to the infection. We can learn a great deal from HIV-infected individuals who have lived for more than ten years and remain healthy without receiving antiviral drugs. These long-term survivors or long-term non-progressors have an immune system that can control HIV infection. A major component of this immune response is innate immunity, particularly the CD8(+) cell antiviral non-cytotoxic response (CNAR), mediated by a novel CD8(+) cell antiviral factor (CAF). The characteristics of CNAR and CAF will be described and progress made toward identifying CAF will be reviewed. These studies have uncovered several potentially important natural anti-HIV factors and their relationship to the originally described CAF is considered.
引用
收藏
页码:628 / 632
页数:5
相关论文
共 64 条
[11]   A soluble factor(s) secreted from CD8+ T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation [J].
Chang, TLY ;
Mosoian, A ;
Pine, R ;
Klotman, ME ;
Moore, JP .
JOURNAL OF VIROLOGY, 2002, 76 (02) :569-581
[12]  
CHEN CC, 1993, ASIA PAC J PHARMACOL, V8, P1
[13]   IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].
COCCHI, F ;
DEVICO, AL ;
GARZINODEMO, A ;
ARYA, SK ;
GALLO, RC ;
LUSSO, P .
SCIENCE, 1995, 270 (5243) :1811-1815
[14]   SUPPRESSION OF ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS LONG TERMINAL REPEAT BY CD8(+) T-CELLS IS NOT LENTIVIRUS SPECIFIC [J].
COPELAND, KFT ;
MCKAY, PJ ;
ROSENTHAL, KL .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (11) :1321-1326
[15]   The complexity of protective immunity against liver-stage malaria [J].
Doolan, DL ;
Hoffman, SL .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1453-1462
[16]   HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor [J].
Feng, Yu ;
Broder, Christopher C. ;
Kennedy, Paul E. ;
Berger, Edward A. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (11) :872-877
[17]   HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family [J].
Geiben-Lynn, R ;
Kursar, M ;
Brown, NV ;
Addo, MM ;
Shau, H ;
Lieberman, J ;
Luster, AD ;
Walker, BD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1569-1574
[18]   Purification of a modified form of bovine antithrombin III as an HIV-1CD8+ T-cell antiviral factor [J].
Geiben-Lynn, R ;
Brown, N ;
Walker, BD ;
Luster, AD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (44) :42352-42357
[19]   Noncytolytic inhibition of X4 virus by bulk CD8+ cells from human immunodeficiency virus type 1 (HIV-1)-Infected persons and HIV-1-Specific cytotoxic T lymphocytes is not mediated by β-chemokines [J].
Geiben-Lynn, R ;
Kursar, M ;
Brown, NV ;
Kerr, EL ;
Luster, AD ;
Walker, BD .
JOURNAL OF VIROLOGY, 2001, 75 (17) :8306-8316
[20]  
GOMEZ AM, 1994, CLIN EXP IMMUNOL, V97, P68